Nearly 61% of physicians polled have a pessimistic outlook toward PE compared to 11% who view it positively, and 29% who hold a neutral opinion on such investors' involvement in the field.
Generative AI has the potential to revolutionize the way we treat disease, develop new medicines and personalize treatments to fit individual patients.